These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7999882)

  • 1. Protection of mice against Aujeszky's disease virus infection by intranasal vaccination with inactivated virus.
    Takada A; Shimizu Y; Kida H
    J Vet Med Sci; 1994 Aug; 56(4):633-7. PubMed ID: 7999882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of protective antibody responses against pseudorabies virus by intranasal vaccination with glycoprotein B in mice.
    Takada A; Kida H
    Arch Virol; 1995; 140(9):1629-35. PubMed ID: 7487494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal vaccination of pigs against Aujeszky's disease: comparison with one or two doses of attenuated vaccines in pigs with high maternal antibody titres.
    Van Oirschot JT
    Res Vet Sci; 1987 Jan; 42(1):12-6. PubMed ID: 3029845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal vaccination of pigs against Aujeszky's disease: comparison with inactivated vaccines in pigs with low maternal antibody titres.
    De Leeuw PW; Van Oirschot JT
    Res Vet Sci; 1985 Jul; 39(1):34-8. PubMed ID: 2994188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of dogs against pseudorabies (Aujeszky's disease), using an inactivated-virus vaccine.
    Pensaert MB; Commeyne S; Andries K
    Am J Vet Res; 1980 Dec; 41(12):2016-9. PubMed ID: 6259977
    [No Abstract]   [Full Text] [Related]  

  • 6. Intranasal vaccination of pigs against Aujeszky's disease. 4. Comparison with one or two doses of an inactivated vaccine in pigs with moderate maternal antibody titres.
    Van Oirschot JT; De Leeuw PW
    Vet Microbiol; 1985 Aug; 10(5):401-8. PubMed ID: 2996212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the protective efficacy of Aujeszky's disease (pseudorabies) virus glycoproteins obtained from different sources.
    Puentes E; Eiras A; Cancio E; Nores MV; Aguilera A; Seoane R; Regueiro BJ
    Vet Microbiol; 1993 May; 35(1-2):45-59. PubMed ID: 8395745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination of cattle against pseudorabies (Aujeszky's disease) with homologous virus (herpes suis) and heterologous virus (herpes bovis 1).
    Biront P; Vandeputte J; Pensaert MB; Leunen J
    Am J Vet Res; 1982 May; 43(5):760-3. PubMed ID: 6283963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local humoral and cellular responses in Aujeszky's disease virus infection in pigs.
    Martin S; Wardley RC
    Res Vet Sci; 1987 Mar; 42(2):170-4. PubMed ID: 3035662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal and systemic immune responses to Aujeszky's disease virus (ADV) in early vaccinated piglets.
    Salinas-Zacarias I; Guzman-Bautista ER; Ramírez-Estudillo MDC; Chacón-Salinas R; Vega-López MA
    Comp Immunol Microbiol Infect Dis; 2020 Feb; 68():101400. PubMed ID: 31794953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal vaccination of pigs against Aujeszky's disease: protective immunity at 2 weeks, 2 months and 4 months after vaccination in pigs with maternal antibodies.
    van Oirschot JT
    Vet Microbiol; 1991 Apr; 27(2):103-13. PubMed ID: 1648282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of mice from lethal infection with Aujeszky's disease virus by immunization with purified gVI.
    Ishii H; Kobayashi Y; Kuroki M; Kodama Y
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1411-4. PubMed ID: 2838579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective immune response of chickens against Newcastle disease, induced by the intranasal vaccination with inactivated virus.
    Takada A; Kida H
    Vet Microbiol; 1996 May; 50(1-2):17-25. PubMed ID: 8810004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
    Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of intranasal vaccination with plasmid encoding pseudorabies virus glycoprotein B in mice.
    Takada A; Okazaki K; Kida H
    Jpn J Vet Res; 1999 Aug; 47(1-2):25-33. PubMed ID: 10810559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination of pigs against Aujeszky's disease by the intradermal route using live attenuated and inactivated virus vaccines.
    Vannier P; Cariolet R
    Vet Microbiol; 1991 Jan; 26(1-2):11-23. PubMed ID: 1850888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination.
    Hirabayashi Y; Kurata H; Funato H; Nagamine T; Aizawa C; Tamura S; Shimada K; Kurata T
    Vaccine; 1990 Jun; 8(3):243-8. PubMed ID: 2363302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses and protection in mice immunized orally against influenza virus.
    Takase H; Murakami Y; Endo A; Ikeuchi T
    Vaccine; 1996 Dec; 14(17-18):1651-6. PubMed ID: 9032895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination of pigs against Aujeszky's disease by the intradermal route using live attenuated and inactivated virus vaccines.
    Vannier P; Cariolet R
    Zentralbl Veterinarmed B; 1989 Sep; 36(7):515-26. PubMed ID: 2554623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein I.
    van Oirschot JT; Terpstra C; Moormann RJ; Berns AJ; Gielkens AL
    Vet Rec; 1990 Nov; 127(18):443-6. PubMed ID: 2177288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.